2009 - Member of the National Academy of Medicine (NAM)
Member of the Association of American Physicians
His scientific interests lie mostly in Fibrodysplasia ossificans progressiva, Heterotopic ossification, Pathology, ACVR1 and Ossification. His Fibrodysplasia ossificans progressiva study incorporates themes from Genetic disorder, Disease, Myositis ossificans, Endochondral ossification and Bone morphogenetic protein. Frederick S. Kaplan studied Heterotopic ossification and Penetrance that intersect with Dermatology, Pseudopseudohypoparathyroidism and STX16.
The Pathology study which covers Stem cell that intersects with Aplastic anemia, Bone marrow, Transplantation and Myocyte. His ACVR1 research includes themes of Mutation, Chondrogenesis, Connective tissue and Anatomy. His Ossification study integrates concerns from other disciplines, such as Heart valve, Progressive osseous heteroplasia and Bone remodeling.
His primary areas of investigation include Fibrodysplasia ossificans progressiva, Heterotopic ossification, ACVR1, Pathology and Bone morphogenetic protein. Frederick S. Kaplan has included themes like Internal medicine, Myositis ossificans, Endochondral ossification and Endocrinology in his Fibrodysplasia ossificans progressiva study. The study incorporates disciplines such as Ossification, Genetic disorder, Disease and Progressive osseous heteroplasia in addition to Heterotopic ossification.
His ACVR1 research is multidisciplinary, relying on both Mutation, BMPR2, BMP signaling pathway and Bioinformatics. His Pathology study combines topics from a wide range of disciplines, such as Progenitor cell, Stem cell and Cartilage. His Bone morphogenetic protein research is multidisciplinary, incorporating elements of Cancer research, Activin receptor, Signal transduction, Cell biology and Bone morphogenetic protein 2.
Frederick S. Kaplan spends much of his time researching Fibrodysplasia ossificans progressiva, Heterotopic ossification, ACVR1, Bone morphogenetic protein and Myositis ossificans. His Fibrodysplasia ossificans progressiva research includes elements of Dermatology, Natural history study, Internal medicine, Endochondral ossification and Pediatrics. Frederick S. Kaplan combines subjects such as Ossification and Genetic disorder, Disease, Pathology with his study of Heterotopic ossification.
His work deals with themes such as Mast cell and Progressive osseous heteroplasia, which intersect with Pathology. His study in ACVR1 is interdisciplinary in nature, drawing from both Mutation, Cancer research, Clinical trial and Connective tissue. His biological study spans a wide range of topics, including Progenitor cell, Signal transduction, Stem cell, Cell biology and Activin receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Bone Formation and Inflammation in Cardiac Valves
Emile R. Mohler;Francis Gannon;Carol Reynolds;Robert Zimmerman.
Circulation (2001)
A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva
Eileen M Shore;Meiqi Xu;George J Feldman;David A Fenstermacher.
Nature Genetics (2006)
Overexpression of an Osteogenic Morphogen in Fibrodysplasia Ossificans Progressiva
Adam B. Shafritz;Eileen M. Shore;Francis H. Gannon;Michael A. Zasloff.
The New England Journal of Medicine (1996)
Treatment of Osteoporosis: Are Physicians Missing an Opportunity?*†
Kevin B. Freedman;Frederick S. Kaplan;Warren B. Bilker;Brian L. Strom.
Journal of Bone and Joint Surgery, American Volume (2000)
Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.
Frederick S. Kaplan;Meiqi Xu;Petra Seemann;J. Michael Connor.
Human Mutation (2009)
The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients.
Randolph B. Cohen;Gregory V. Hahn;Jeffrey A. Tabas;Jeannie Peeper.
Journal of Bone and Joint Surgery, American Volume (1993)
Identification of Progenitor Cells That Contribute to Heterotopic Skeletogenesis
Vitali Y. Lounev;Rageshree Ramachandran;Michael N. Wosczyna;Masakazu Yamamoto.
Journal of Bone and Joint Surgery, American Volume (2009)
Fibrodysplasia ossificans progressiva
Frederick S. Kaplan;Martine Le Merrer;David L. Glaser;Robert J. Pignolo.
Best Practice & Research: Clinical Rheumatology (2008)
Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia.
Eileen M. Shore;Jaimo Ahn;Suzanne Jan de Beur;Ming Li;Ming Li.
The New England Journal of Medicine (2002)
The Histopathology of Fibrodysplasia Ossificans Progressiva. An Endochondral Process.
Frederick S. Kaplan;Jeffrey A. Tabas;Francis H. Gannon;Gerald Finkel.
Journal of Bone and Joint Surgery, American Volume (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Guy's and St Thomas' NHS Foundation Trust
American College of Medical Genetics
Regeneron (United States)
University of Pennsylvania
University of Oxford
Emory University
University of Pennsylvania
Columbia University
Vanderbilt University Medical Center
University of Pennsylvania
University of North Carolina at Chapel Hill
Northeastern University
University of Pisa
Universidade Federal de Santa Maria
Pohang University of Science and Technology
Cornell University
University of Minnesota
Arizona State University
University of Lausanne
University of Michigan–Ann Arbor
Ruhr University Bochum
University of California, San Diego
Duke University
Institute of Cancer Research
University of Manchester
University of Michigan–Ann Arbor